摘要
复苏性主动脉球囊阻断术(REBOA)在不可压迫性躯干出血、心搏骤停等危重症的救治中已表现出显著效果,具有效果确切、操作快捷、微创、可就地实施等特点。然而,屡见不鲜的并发症事件也使得该技术的治疗效果饱受争议。危重病抢救的治疗容错率很低,而血管通路、缺血、再灌注等相关的并发症一旦发生,将给患者的存活率和生存质量带来严重影响。本文旨在探讨REBOA在急危重症中的作用机制、安全性与有效性及临床应用进展,以期为临床应用和效果优化提供参考依据。
Resuscitative endovascular balloon occlusion of the aorta(REBOA)has shown remarkable effect in the treatment of critical diseases such as non-compressible torso hemorrhage and cardiac arrest.It has the characteristics of accurate effect,rapid operation,minimally invasive and local implementation.However,frequent complications have even caused controversy about the therapeutic effect of this technique.The tolerance for error in critical care resuscitation is very low,and complications related to vascular access,ischemia,and reperfusion,if they occur,can have a serious impact on both the survival rate and quality of life of the patients.This paper aims to explore the mechanism of action,safety,effectiveness,and clinical application progress of REBOA in critical and emergency situations,with the hope of providing reference for clinical application and optimization of effects.
作者
徐帅
徐杰丰
李雨林
郑忠骏
张茂
XU Shuai;XU Jiefeng;LI Yulin;ZHENG Zhongjun;ZHANG Mao(Department of Emergency Medicine,The Second Affiliated Hospital Zhejiang University School of Medicine,Hangzhou 310009,China;Department of Emergency,Jiaxing Hospital of Traditional Chinese Medicine,Jiaxing 314000,China)
出处
《中国医药指南》
2024年第24期71-74,共4页
Guide of China Medicine
基金
浙江省重点研发计划项目(2021C03073)
浙江省医药卫生科技计划-省部共建重大项目(WKJ-ZJ-2207)
浙江省医药卫生科技计划项目(2023KY774)
浙江省自然科学基金探索项目(LQ21H150004)。
关键词
创伤性心搏骤停
非创伤性心搏骤停
非压迫性躯干出血
综述
Traumatic cardiac arrest
Non-traumatic cardiac arrest
Non-compressible torso hemorrhage
Review
